Treatment of Cellulitis in Patients with Multiple Antibiotic Allergies

First-Line Treatment Options

The Infectious Diseases Society of America recommends clindamycin 300-450 mg orally three times daily as the first-line treatment for cellulitis in patients with multiple antibiotic allergies 1, 2
Clindamycin provides excellent coverage against both streptococci and staphylococci, making it an ideal alternative when first-line agents cannot be used 1, 3
For patients requiring parenteral therapy due to severity of infection, intravenous clindamycin 600 mg three times daily is recommended 2, 4

Doxycycline or minocycline can be used as alternatives, particularly in areas with high MRSA prevalence 3, 5
Vancomycin is recommended for severe infections requiring hospitalization, as it covers both streptococci and MRSA 1, 3

A 5-day course of antibiotic treatment is as effective as a 10-day course for uncomplicated cellulitis if clinical improvement occurs 2, 6
Treatment should be extended if the infection has not improved within the initial 5-day period 1, 6
MRSA coverage may be prudent in certain situations, such as cellulitis associated with penetrating trauma, history of intravenous drug use, presence of purulent drainage, or concurrent evidence of MRSA infection elsewhere 1, 3, 4, 5, 7

Elevation of the affected area is important to promote gravity drainage of edema and inflammatory substances 2, 6, 7
Identify and treat predisposing conditions such as tinea pedis, venous insufficiency, or trauma 1, 6
Consider inpatient treatment with parenteral antibiotics if signs of systemic illness, rapid progression of infection, immunocompromised state, or failure of outpatient therapy are present 1, 3, 6

Address predisposing factors such as edema, obesity, venous insufficiency, or toe web abnormalities to prevent recurrence 1, 6
Failing to distinguish between cellulitis and abscess, and unnecessarily broad antibiotic coverage when treating typical cellulitis, are common pitfalls to avoid 5, 8, 9